• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

Biotech drug discovery companies
Jeito, INKEF, Forbion lead EUR 80m Series B for Precirix

Precirix last raised a EUR 37m Series A in 2018

  • Healthcare
  • 16 March 2022
Fundraising in euros
Gilde Healthcare closes fourth buyout fund on EUR 517m

Double the size of its predecessor, the new vehicle was oversubscribed and saw nearly all Gilde’s existing LPs investing

  • Healthcare
  • 16 March 2022
Veterinary clinics
I Asset Management, BaltCap acquire Dr Vet

IAM has a specialist Petcare Growth Fund

  • Healthcare
  • 15 March 2022
Dermatologist examining a patient
Ufenau moves Corius and Altano to continuation fund

Bought in 2017, the dermatology and vet groups have been transferred into the Swiss GP’s third continuation vehicle

  • Secondaries
  • 15 March 2022
Disability care and education
Queen's Park Equity backs Blue Ribbon MBO

The deal is the sixth from QPE's Equity Fund I

  • Buyouts
  • 14 March 2022
In vitro diagnostics
GED completes Vitro exit in single asset vehicle deal

GP reaps gross return of 4.0x invested capital and 38% IRR; deal follows sale of Vitro subsidiary to trade in January

  • Secondaries
  • 10 March 2022
Agriculture and food production
Cinven buys Bayer's Environmental Science Professional for EUR 2.4bn

It is the third industrial carve out by the GP since 2020

  • Buyouts
  • 10 March 2022
Fundraising in euros
Nord Holding launches Small-Cap Fund

Small-Cap strategy will be led from Frankfurt by former VR Equitypartner executive Jan Markus Drees

  • Buyout
  • 09 March 2022
Medication and pharmaceutical products
CVC collects first round bids for Theramex

Rothschild and HSBC are advising on the sale of the UK-based women’s health pharma company

  • Exits
  • 09 March 2022
Healthcare equipment
Limerston exits Prism to Charme

Charme will complete the deal through Charme IV, which has raised EUR 700m to date

  • Healthcare
  • 03 March 2022
Healthcare software
Gilde Equity Management explores Avinty exit advised by Arma

Sale documents for the Dutch healthcare software provider are expected in Q2 2022

  • Exits
  • 03 March 2022
Digital healthcare recruitment services
Doxx to collect initial bids amid fierce midmarket sponsor interest

German digital healthcare staffing specialist has attracted GPs such as IK, DPE, Ardian, Chequers, Triton, PAI, Equistone, Rivean Capital

  • Buyouts
  • 28 February 2022
Surgery devices
Evoco makes three-company Austrian portfolio deal

Deal sees the GP acquire companies from AWS Mittelstandsfonds including medical technology firm AMI

  • Buyouts
  • 24 February 2022
Dental equipment
Palamon to carve out Dental Directory from IDH Group

Adviser DC Advisory has distributed materials marketing the asset off GBP 15m EBITDA

  • Exits
  • 24 February 2022
Dentures and dentistry
Motion readies Minlay for sale advised by Natixis Partners

Apax, Charterhouse and IK are eyeing the French dental prosthetic devices company

  • Exits
  • 24 February 2022
Medical software
IK small cap fund invests in Sofia

The company has EUR 20m of revenue.

  • Healthcare
  • 23 February 2022
In-vitro biotechnology and diagnostics
Axcel exits Aidian to Nordstjernan

The GP had also been planning a Helsinki listing

  • Healthcare
  • 22 February 2022
Hospital scanning equipment for oncology and radiology
Triton partially exits Aleris to EQT Infrastructure for EUR 286m

The GP has sold the radiology arm for 11x EBITDA.

  • Healthcare
  • 22 February 2022
Computer animation of DNA strand
UCB, Ysios lead EUR 50m Series A for SpliceBio

Round for the gene therapy specialist is the largest ever Series A for a Spanish biotechnology company

  • Expansion
  • 16 February 2022
Dollar-denominated life sciences fund
Pictet holds first close for healthcare fund-of-funds

Around 40% of the target USD 400m will be allocated to co- and direct investments

  • Fund-of-funds
  • 16 February 2022
Fundraising in euros
Astorg closes Mid-Cap Fund on EUR 1.3bn

Fund will target EUR 150m-500m EV deals, expanding on Astorg’s current flagship strategy

  • Buyout
  • 15 February 2022
Healthcare apps and software
Vaaka buys Medbase as fund III approaches full deployment

The GP made the deal from its Buyout III fund

  • Nordics
  • 15 February 2022
Medical tools sterilisation machines
Cathay Capital readies Cenexi for exit

Natixis and Jefferies will advise on the upcoming sale of the French CDMO specialised in high sterile products

  • Exits
  • 15 February 2022
Forecast fundraising closes
LSP closes LSP 7 at EUR 1bn

The GP says it is the largest life sciences venture capital fund ever raised in Europe

  • Funds
  • 14 February 2022
12 13 14
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013